Daniel P. Maher

Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA.

Catalina Marketing Corp. provides consumer-driven marketing solutions to brand manufacturers, retailers and health providers. It offers in-store, mobile, and digital brand building solutions that enable consumer and retail brands to build its online, social media, and loyalty programs to acquire consumers for new and established brands. The company was founded by Tom Mindrum, Michael O'Brien, George W. Off, Mike Scroggie and Brian Yeatman in 1983 and is headquartered in St. Petersburg, FL.

Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania.

Firecomms Ltd. develops semiconductor related devices. It provides lasers and LEDs provide the groundwork that will revolutionize optical data communications for small area networks, such as in-car networks and home networks. It offers low power visible lasers unleash the potential for medical devices, barcode scanners and optical storage devices. The company was founded by John Lambkin and Thomas Moriarty in May 2001 and is headquartered in Cork, Ireland.

AGI Therapeutics Plc provides pharmaceutical services. The firm engages in development and commercialization of differentiated drug products to treat unmet medical needs, including conditions which qualify for orphan drug status. The company was founded by John Devane and Patrick Ashe in 2003 and is headquartered in Dublin, Ireland.

Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Kainos Software Ltd. provides digital technology solutions. The firm offers software design, agile software development, third-party software integration and implementation, technology support and related ancillary services. The company was founded in April 1986 and is headquartered in Belfast, the United Kingdom.

Frontier Silicon Ltd. engages in the provision of technology solutions for digital radio and smart audio devices. Its products include chips, modules, platforms, and software. The company was founded by Anthony Ian Sethill in 2001 and is headquartered London, the United Kingdom.

Fair Isaac (Adeptra) Ltd. has been in the business of automated, interactive customer communications since 1996. They focus on the needs of organizations engaged in consumer credit and risk management and this dedication has helped them to become the global market leader in their field. The firm operates headquarters and multiple data centers across North America, EMEA, and APAC. Its collections, fraud and marketing clients reflect this reach and include the majority of the world's consumer finance organizations.

Promedior, Inc. is a clinical-stage immunotherapy company, which engages in the development of targeted therapeutics to treat fibrotic diseases. Its proprietary therapeutic platform is based upon Pentraxin-2, an endogenous human protein that plays an important role in regulating the response to fibrosis. The company was founded by Gomer H. Richard, Lawrence M. Kauvar, and Darrell Pilling in April 2006 and is headquartered in Lexington, MA.

Silicon & Software Systems Ltd. provides products, solutions and professional services to digital television, telehealth and semiconductor industries. It offers StormTest Development Center, a digital TV test automation platform for multiscreen platform end-to-end validation, QA during software development and integration, whitebox testing, multi-device testing, live audio/video quality analysis, live service monitoring and testing, stress testing applications; StormTest Decision Line, an industrial automated testing for screening digital TV devices; and technology consulting, system integration, testing and certification, and test services. The company was founded in 1986 and is headquartered in Leopardstown, Ireland.

Biosensia Ltd. develops multiplexing point of care in vitro diagnostics platform. It offers RapiPlex, a point-of-care diagnosis system based on a set of proprietary technologies capable of producing quantitative and qualitative laboratory quality test results. The company was founded by Gareth Redmond and Gabriel Crean in 2009 and is headquartered in Dublin, Ireland.

Openjaw Technologies Ltd. provides travel distribution software solutions. Its OpenJaw t-Retail Platform gives travel companies to retail all travel products with world's reputed travel brands. The company was founded by John McQuillan, Sean MacRobeaird and John Lambe in 2002 and is headquartered in Dublin, Ireland.

Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA.

Beamax Ltd. operates as a sports social platform that allows sports teams to communicate and engage over the course of sports season. It offers online team management system creation and designing to take the hassle out of managing any sports team. The firm operates as a sports social platform across the web, email and mobile to let players, managers and coaches communicate and organize, taking the hassle out of sports team organization and management. The company was founded by Stephen Moulton, Niall McEvoy and Kenneth Moulton in 2008 and is headquartered in Dublin, Ireland.

ReForm Biologics LLC develops formulation technologies for biotherapeutics molecules. It provides technologies that include Viscosity-reducing excipients, Stability-enhancing excipients, and Surfactant-replacing excipients. The company was founded by David S. Soane and Zachariah Jonasson and is headquartered in Cambridge, MA.

Changeover Technologies Ltd. engages in the process of converting waste to solid fuels. Its FuelForm system changes the economics of pelletising and briqueting fuels and biomass and the substantially lower overall costs of this unique system turns potential customers’ waste into raw materials and makes possible the commercial upgrading and blending of low rank, moisture coals. The company is headquartered in Belfast, the United Kingdom.

NFlection Therapeutics, Inc. operates as a biotechnology company. It focuses on the development of therapies for Neurofibromatosis. The company was founded by Mark de Souza and Michael Wootton in 2014 and is headquartered in Wayne, PA.

Tspan LLC is an American pharmaceutical manufacturing company. The private company is based in New York.

Itero Holdings LLC provides investment services. The private company is based in San Jose, CA.

Part of Comera Life Sciences Holdings, Inc., Comera Life Sciences, Inc. is a company that has developed a technology platform to transform the formulation of biotherapeutics for the benefit of patients. The company is based in Woburn, MA. Reform Biologics, a subsidiary of Comera Life Sciences, offers formulation development collaborations and product-specific licenses for a broad spectrum of protein-based therapeutics. The company's patented technology can extend product life-cycles, enable alternative dosing, and improve manufacturing efficiency for biopharmaceutical partners. Reform Biologics creates gentler therapies for fragile patients, including pediatric patients, by using their proprietary technology to transform intravenous drugs into subcutaneous injections, to reduce adverse reactions, and to improve drug stability. The company's goal is to enhance comfort, convenience, safety, and compliance so that patients living with debilitating diseases can experience a better life while treating their medical conditions. The company was founded by David S. Soane, Zachariah Jonasson, and Jeffrey S Hackman has been the CEO of the company since 2021. Comera Life Sciences was acquired by OTR Acquisition Corp. on May 20, 2022 for $156.08 million.

Itero Biopharmaceuticals LLC provides royalty payment services for licensing agreements. The American company was founded by V. Bryan Lawlis.